Transcode completes initial dosing of first cohort in trial with TTX-MC138
PremiumThe FlyTranscode completes initial dosing of first cohort in trial with TTX-MC138
1M ago
Transcode announces first patients treated in Phase 1 trial of TTX-MC138
Premium
The Fly
Transcode announces first patients treated in Phase 1 trial of TTX-MC138
2M ago
Transcode Therapeutics announces publication of study on TTX-MC138
Premium
The Fly
Transcode Therapeutics announces publication of study on TTX-MC138
2M ago
Transcode Therapeutics regains compliance with Nasdaq listing requirements
PremiumThe FlyTranscode Therapeutics regains compliance with Nasdaq listing requirements
5M ago
Transcode Therapeutics reports data from FIH study of TTX-MC138
Premium
The Fly
Transcode Therapeutics reports data from FIH study of TTX-MC138
6M ago
Transcode Therapeutics board issues letter to shareholders
Premium
The Fly
Transcode Therapeutics board issues letter to shareholders
6M ago
Transcode Therapeutics, Akribion report progress on CRISPR-derived tech
PremiumThe FlyTranscode Therapeutics, Akribion report progress on CRISPR-derived tech
8M ago
Transcode Therapeutics reports publication of U.S. patent application
Premium
The Fly
Transcode Therapeutics reports publication of U.S. patent application
9M ago
TransCode Therapeutics Regains Nasdaq Compliance Status
Premium
Company Announcements
TransCode Therapeutics Regains Nasdaq Compliance Status
10M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100